Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.

Yasuda A, Sawai H, Takahashi H, Ochi N, Matsuo Y, Funahashi H, Sato M, Okada Y, Takeyama H, Manabe T.

Mol Cancer. 2006 Oct 18;5:46.

2.

Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).

Ali S, Ali S.

Gene. 2007 Oct 15;401(1-2):38-45. Epub 2007 Jul 3. Review.

PMID:
17659849
3.

Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.

Reber L, Da Silva CA, Frossard N.

Eur J Pharmacol. 2006 Mar 8;533(1-3):327-40. Epub 2006 Feb 17. Review.

PMID:
16483568
4.

Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.

Demetri GD.

Semin Oncol. 2001 Oct;28(5 Suppl 17):19-26. Review.

PMID:
11740803
5.

The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer.

Roussidis AE, Theocharis AD, Tzanakakis GN, Karamanos NK.

Curr Med Chem. 2007;14(7):735-43. Review.

PMID:
17346159
6.

The SCF/c-KIT system in the male: Survival strategies in fertility and cancer.

Cardoso HJ, Figueira MI, Correia S, Vaz CV, Socorro S.

Mol Reprod Dev. 2014 Dec;81(12):1064-79. doi: 10.1002/mrd.22430. Epub 2014 Oct 30. Review.

PMID:
25359157
7.

C-KIT signaling in cancer treatment.

Stankov K, Popovic S, Mikov M.

Curr Pharm Des. 2014;20(17):2849-80. Review.

PMID:
23944364
8.

Dendritic cell c-kit signaling and adaptive immunity: implications for the upper airways.

Oriss TB, Krishnamoorthy N, Ray P, Ray A.

Curr Opin Allergy Clin Immunol. 2014 Feb;14(1):7-12. doi: 10.1097/ACI.0000000000000019. Review.

9.

The C-kit receptor-mediated signal transduction and tumor-related diseases.

Liang J, Wu YL, Chen BJ, Zhang W, Tanaka Y, Sugiyama H.

Int J Biol Sci. 2013 May 8;9(5):435-43. doi: 10.7150/ijbs.6087. Print 2013. Review.

10.

The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?

Figueira MI, Cardoso HJ, Correia S, Maia CJ, Socorro S.

Cancer Lett. 2017 Oct 1;405:10-21. doi: 10.1016/j.canlet.2017.07.017. Epub 2017 Jul 24. Review.

PMID:
28751268
11.

Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation.

Ray P, Krishnamoorthy N, Ray A.

Cell Cycle. 2008 Sep 15;7(18):2826-32. Epub 2008 Sep 7. Review.

12.

A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Feng ZC, Riopel M, Popell A, Wang R.

Diabetologia. 2015 Apr;58(4):654-65. doi: 10.1007/s00125-015-3504-0. Epub 2015 Feb 3. Review.

PMID:
25643653
13.

Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.

Jensen BM, Akin C, Gilfillan AM.

Br J Pharmacol. 2008 Aug;154(8):1572-82. doi: 10.1038/bjp.2008.204. Epub 2008 May 26. Review.

14.

Merkel cell carcinoma: lack of KIT positivity and implications for the use of imatinib mesylate.

Yang Q, Hornick JL, Granter SR, Wang LC.

Appl Immunohistochem Mol Morphol. 2009 Jul;17(4):276-81. doi: 10.1097/PAI.0b013e318194da49. Review.

PMID:
19276970
15.

Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma.

Marech I, Gadaleta CD, Ranieri G.

Int J Mol Sci. 2014 Jul 23;15(7):13060-76. doi: 10.3390/ijms150713060. Review.

16.

Hormonal regulation of c-KIT receptor and its ligand: implications for human infertility?

Figueira MI, Cardoso HJ, Correia S, Maia CJ, Socorro S.

Prog Histochem Cytochem. 2014 Sep;49(1-3):1-19. doi: 10.1016/j.proghi.2014.09.001. Epub 2014 Nov 1. Review.

PMID:
25451758
17.

Signaling of c-kit in dendritic cells influences adaptive immunity.

Ray P, Krishnamoorthy N, Oriss TB, Ray A.

Ann N Y Acad Sci. 2010 Jan;1183:104-22. doi: 10.1111/j.1749-6632.2009.05122.x. Review.

18.

Masitinib (AB1010), from canine tumor model to human clinical development: where we are?

Marech I, Patruno R, Zizzo N, Gadaleta C, Introna M, Zito AF, Gadaleta CD, Ranieri G.

Crit Rev Oncol Hematol. 2014 Jul;91(1):98-111. doi: 10.1016/j.critrevonc.2013.12.011. Epub 2013 Dec 17. Review.

PMID:
24405856
19.

Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.

Abbaspour Babaei M, Kamalidehghan B, Saleem M, Huri HZ, Ahmadipour F.

Drug Des Devel Ther. 2016 Aug 1;10:2443-59. doi: 10.2147/DDDT.S89114. eCollection 2016. Review.

20.

[Application for therapeutic use of deuterium oxide (D2O) against human pancreatic cancer].

Omori H, Nio Y, Takeda H, Tamura K.

Gan To Kagaku Ryoho. 1996 Oct;23(12):1665-8. Review. Japanese.

PMID:
8886040

Supplemental Content

Support Center